Items tagged with Drug-resistant TB
Advocates call on WHO to consolidate and revise its guidance regarding the treatment for MDR-TB (post with simple image)
TB CAB issues a position statement on the use of bedaquiline as part of the preferred regimen for MDR-TB.
Giorgia Sulis: Delamanid — a broken dream for patients with MDR-TB? (post with simple image)
When the new TB drug delamanid was approved by the European Medicines Agency (EMA) in 2013, it was one of only two new drugs approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in more than 40 years. Preliminary findings suggested that this new drug could have a promising role for treatment when used with an optimised background regimen (OBR)—results that led to the World Health Organization (WHO) conditionally endorsing the drug in 2014 and providing interim policy guidance.
WHO call for patient data on the treatment of drug-resistant TB (post with simple image)
Public call for individual patient data on treatment of multidrug- and rifampicin-resistant TB.
Indian civil society pushes for government use compulsory license on MDR-TB drugs (post with simple image)
Advocates appeal to the Prime Minister of India to issue a government use compulsory license for bedaquiline and delamanid to encourage generic competition.
New guide to shorter regimen for treating drug-resistant TB (post with simple image)
DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis
WHO treatment guidelines for isoniazid-resistant TB (post with simple image)
The World Health Organization issues recommendations on management of isoniazid-resistant TB.
WHO response to STREAM Stage 1 preliminary results (post with simple image)
WHO issues a position statement on the continued use of the shorter MDR-TB regimen following an expedited review of the STREAM Stage 1 preliminary result.
Advocates call for urgent reforms of WHO TB diagnosis and treatment guidelines (post with simple image)
Advocates call on WHO leadership to ensure rapid development of clear, consolidated guidelines for the diagnosis and treatment of TB.
South Africa makes bedaquiline part of its standard recommended treatment regimen for rifampicin-resistant TB (post with simple image)
Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow.
Treatment Action Group welcomes price reductions for TB medicines (post with simple image)
Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.
Page 80 of 82 · Total posts: 0←First 79 80 81 Last→